ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY), a biomedical company aiming to meet women’s needs worldwide by developing a suite of product candidates that include minimally invasive, ...
Education on birth control and its potential adverse effects is vital to women choosing the type that best suits them. Skepticism surrounding hormonal birth control has been increasing nationwide, ...
Hosted on MSN
Is vasectomy right for you?
Vasectomy: The Ultimate Birth Control? Considering a vasectomy? Learn about its effectiveness, risks, and impact on sexual performance. Make an informed choice!...see more Since the Supreme Court ...
ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to ...
ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of ...
Kathy Lee-Sepsick, founder and CEO of Femasys, is blazing a trail in the biomedical industry. Kathy Lee-Sepsick is the founder of Femasys, which makes contraceptive and fertility products, including a ...
--Marks key milestone in European commercialization strategy under EU Medical Device Regulation (MDR)-- ATLANTA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY) (NASDAQ: FEMY), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results